Literature DB >> 32619402

Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases.

Joshua B Sheetz1, Sebastian Mathea2, Hanna Karvonen3, Ketan Malhotra1, Deep Chatterjee4, Wilhelmiina Niininen3, Robert Perttilä3, Franziska Preuss4, Krishna Suresh5, Steven E Stayrook1, Yuko Tsutsui1, Ravi Radhakrishnan5, Daniela Ungureanu6, Stefan Knapp7, Mark A Lemmon8.   

Abstract

Despite their apparent lack of catalytic activity, pseudokinases are essential signaling molecules. Here, we describe the structural and dynamic properties of pseudokinase domains from the Wnt-binding receptor tyrosine kinases (PTK7, ROR1, ROR2, and RYK), which play important roles in development. We determined structures of all pseudokinase domains in this family and found that they share a conserved inactive conformation in their activation loop that resembles the autoinhibited insulin receptor kinase (IRK). They also have inaccessible ATP-binding pockets, occluded by aromatic residues that mimic a cofactor-bound state. Structural comparisons revealed significant domain plasticity and alternative interactions that substitute for absent conserved motifs. The pseudokinases also showed dynamic properties that were strikingly similar to those of IRK. Despite the inaccessible ATP site, screening identified ATP-competitive type-II inhibitors for ROR1. Our results set the stage for an emerging therapeutic modality of "conformational disruptors" to inhibit or modulate non-catalytic functions of pseudokinases deregulated in disease.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GZD824; Wnt signaling; cancer; growth factor signaling; ponatinib; protein conformation; pseudokinases; receptor tyrosine kinases; targeted therapies

Mesh:

Substances:

Year:  2020        PMID: 32619402      PMCID: PMC7543951          DOI: 10.1016/j.molcel.2020.06.018

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  95 in total

1.  Functional analysis of H-Ryk, an atypical member of the receptor tyrosine kinase family.

Authors:  R M Katso; R B Russell; T S Ganesan
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Multiple activation loop conformations and their regulatory properties in the insulin receptor's kinase domain.

Authors:  A J Ablooglu; M Frankel; E Rusinova; J B Ross; R A Kohanski
Journal:  J Biol Chem       Date:  2001-10-11       Impact factor: 5.157

Review 3.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

4.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

5.  The DynDom3D Webserver for the Analysis of Domain Movements in Multimeric Proteins.

Authors:  Christopher Girdlestone; Steven Hayward
Journal:  J Comput Biol       Date:  2015-11-05       Impact factor: 1.479

Review 6.  The secret life of kinases: insights into non-catalytic signalling functions from pseudokinases.

Authors:  Annette V Jacobsen; James M Murphy
Journal:  Biochem Soc Trans       Date:  2017-06-15       Impact factor: 5.407

7.  Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region.

Authors:  L E Wybenga-Groot; B Baskin; S H Ong; J Tong; T Pawson; F Sicheri
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

8.  Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase.

Authors:  Yibing Shan; Kavitha Gnanasambandan; Daniela Ungureanu; Eric T Kim; Henrik Hammarén; Kazuo Yamashita; Olli Silvennoinen; David E Shaw; Stevan R Hubbard
Journal:  Nat Struct Mol Biol       Date:  2014-06-11       Impact factor: 15.369

Review 9.  Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments.

Authors:  Glenn R Masson; John E Burke; Natalie G Ahn; Ganesh S Anand; Christoph Borchers; Sébastien Brier; George M Bou-Assaf; John R Engen; S Walter Englander; Johan Faber; Rachel Garlish; Patrick R Griffin; Michael L Gross; Miklos Guttman; Yoshitomo Hamuro; Albert J R Heck; Damian Houde; Roxana E Iacob; Thomas J D Jørgensen; Igor A Kaltashov; Judith P Klinman; Lars Konermann; Petr Man; Leland Mayne; Bruce D Pascal; Dana Reichmann; Mark Skehel; Joost Snijder; Timothy S Strutzenberg; Eric S Underbakke; Cornelia Wagner; Thomas E Wales; Benjamin T Walters; David D Weis; Derek J Wilson; Patrick L Wintrode; Zhongqi Zhang; Jie Zheng; David C Schriemer; Kasper D Rand
Journal:  Nat Methods       Date:  2019-06-27       Impact factor: 28.547

10.  Disease Variants of FGFR3 Reveal Molecular Basis for the Recognition and Additional Roles for Cdc37 in Hsp90 Chaperone System.

Authors:  Tom D Bunney; Alison J Inglis; Domenico Sanfelice; Brendan Farrell; Christopher J Kerr; Gary S Thompson; Glenn R Masson; Nethaji Thiyagarajan; Dmitri I Svergun; Roger L Williams; Alexander L Breeze; Matilda Katan
Journal:  Structure       Date:  2018-02-22       Impact factor: 5.006

View more
  18 in total

1.  Type II Binders Targeting the "GLR-Out" Conformation of the Pseudokinase STRADα.

Authors:  Ryan H B Smith; Zaigham M Khan; Peter Man-Un Ung; Alex P Scopton; Lisa Silber; Seshat M Mack; Alexander M Real; Avner Schlessinger; Arvin C Dar
Journal:  Biochemistry       Date:  2021-01-13       Impact factor: 3.162

2.  ROR and RYK extracellular region structures suggest that receptor tyrosine kinases have distinct WNT-recognition modes.

Authors:  Fumin Shi; Jeannine M Mendrola; Joshua B Sheetz; Neo Wu; Anselm Sommer; Kelsey F Speer; Jasprina N Noordermeer; Zhong-Yuan Kan; Kay Perry; S Walter Englander; Steven E Stayrook; Lee G Fradkin; Mark A Lemmon
Journal:  Cell Rep       Date:  2021-10-19       Impact factor: 9.423

Review 3.  Looking lively: emerging principles of pseudokinase signaling.

Authors:  Joshua B Sheetz; Mark A Lemmon
Journal:  Trends Biochem Sci       Date:  2022-05-16       Impact factor: 14.264

4.  Dynamics of protein kinases and pseudokinases by HDX-MS.

Authors:  Joshua B Sheetz; Mark A Lemmon; Yuko Tsutsui
Journal:  Methods Enzymol       Date:  2022-04-08       Impact factor: 1.682

5.  Multi-Omics Data Analyses Construct a Six Immune-Related Genes Prognostic Model for Cervical Cancer in Tumor Microenvironment.

Authors:  Fangfang Xu; Jiacheng Shen; Shaohua Xu
Journal:  Front Genet       Date:  2021-05-24       Impact factor: 4.599

Review 6.  The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention.

Authors:  Kerstin Menck; Saskia Heinrichs; Cornelia Baden; Annalen Bleckmann
Journal:  Cells       Date:  2021-01-12       Impact factor: 6.600

7.  Dimeric Structure of the Pseudokinase IRAK3 Suggests an Allosteric Mechanism for Negative Regulation.

Authors:  Sven M Lange; Marina I Nelen; Philip Cohen; Yogesh Kulathu
Journal:  Structure       Date:  2020-11-24       Impact factor: 5.006

8.  Conformational interconversion of MLKL and disengagement from RIPK3 precede cell death by necroptosis.

Authors:  Sarah E Garnish; Yanxiang Meng; Akiko Koide; Jarrod J Sandow; Eric Denbaum; Annette V Jacobsen; Wayland Yeung; Andre L Samson; Christopher R Horne; Cheree Fitzgibbon; Samuel N Young; Phoebe P C Smith; Andrew I Webb; Emma J Petrie; Joanne M Hildebrand; Natarajan Kannan; Peter E Czabotar; Shohei Koide; James M Murphy
Journal:  Nat Commun       Date:  2021-04-13       Impact factor: 14.919

9.  Heterozygous Recurrent Mutations Inducing Dysfunction of ROR2 Gene in Patients With Short Stature.

Authors:  Baoheng Gui; Chenxi Yu; Xiaoxin Li; Sen Zhao; Hengqiang Zhao; Zihui Yan; Xi Cheng; Jiachen Lin; Haiyang Zheng; Jiashen Shao; Zhengye Zhao; Lina Zhao; Yuchen Niu; Zhi Zhao; Huizi Wang; Bobo Xie; Xianda Wei; Chunrong Gui; Chuan Li; Shaoke Chen; Yi Wang; Yanning Song; Chunxiu Gong; Terry Jianguo Zhang; Xin Fan; Zhihong Wu; Yujun Chen; Nan Wu
Journal:  Front Cell Dev Biol       Date:  2021-04-14

10.  Pan-Cancer Analysis of Human Kinome Gene Expression and Promoter DNA Methylation Identifies Dark Kinase Biomarkers in Multiple Cancers.

Authors:  Siddesh Southekal; Nitish Kumar Mishra; Chittibabu Guda
Journal:  Cancers (Basel)       Date:  2021-03-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.